JP2024518413A - 修飾ヌクレアーゼ - Google Patents

修飾ヌクレアーゼ Download PDF

Info

Publication number
JP2024518413A
JP2024518413A JP2023568340A JP2023568340A JP2024518413A JP 2024518413 A JP2024518413 A JP 2024518413A JP 2023568340 A JP2023568340 A JP 2023568340A JP 2023568340 A JP2023568340 A JP 2023568340A JP 2024518413 A JP2024518413 A JP 2024518413A
Authority
JP
Japan
Prior art keywords
composition
seq
sequence
cell
nls
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023568340A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024518413A5 (cg-RX-API-DMAC7.html
Inventor
ローランド バウムガートナー
ターニャ ワルネッケ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Artisan Development Labs Inc
Original Assignee
Artisan Development Labs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Artisan Development Labs Inc filed Critical Artisan Development Labs Inc
Publication of JP2024518413A publication Critical patent/JP2024518413A/ja
Publication of JP2024518413A5 publication Critical patent/JP2024518413A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C12N9/222—Clustered regularly interspaced short palindromic repeats [CRISPR]-associated [CAS] enzymes
    • C12N9/226—Class 2 CAS enzyme complex, e.g. single CAS protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2023568340A 2021-05-06 2022-05-06 修飾ヌクレアーゼ Pending JP2024518413A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163185315P 2021-05-06 2021-05-06
US63/185,315 2021-05-06
US202263315483P 2022-03-01 2022-03-01
US63/315,483 2022-03-01
PCT/US2022/028208 WO2022236147A1 (en) 2021-05-06 2022-05-06 Modified nucleases

Publications (2)

Publication Number Publication Date
JP2024518413A true JP2024518413A (ja) 2024-05-01
JP2024518413A5 JP2024518413A5 (cg-RX-API-DMAC7.html) 2025-05-13

Family

ID=81975392

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023568340A Pending JP2024518413A (ja) 2021-05-06 2022-05-06 修飾ヌクレアーゼ

Country Status (4)

Country Link
US (2) US20260009009A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024518413A (cg-RX-API-DMAC7.html)
CA (1) CA3218053A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022236147A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023122762A1 (en) 2021-12-22 2023-06-29 Camp4 Therapeutics Corporation Modulation of gene transcription using antisense oligonucleotides targeting regulatory rnas
JP2026523341A (ja) 2023-05-15 2026-07-14 エヌクロマ・バイオ,インコーポレーテッド Hbv遺伝子発現のエピジェネティック調節のための組成物および方法
WO2026046724A1 (en) * 2024-08-30 2026-03-05 Cellectis Sa Tale protein scaffolds involving fusions of monopartite and bipartite nls

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020109412A1 (en) * 2018-11-28 2020-06-04 Keygene N.V. Targeted enrichment by endonuclease protection
JP2020530264A (ja) * 2017-06-23 2020-10-22 インスクリプタ, インコーポレイテッド 核酸誘導型ヌクレアーゼ
US20200354703A1 (en) * 2018-10-22 2020-11-12 Inscripta, Inc. Engineered enzymes
WO2020254357A1 (en) * 2019-06-19 2020-12-24 F. Hoffmann-La Roche Ag Method for the generation of a protein expressing cell by targeted integration using cre mrna
WO2021067788A1 (en) * 2019-10-03 2021-04-08 Artisan Development Labs, Inc. Crispr systems with engineered dual guide nucleic acids

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9790490B2 (en) 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
EP3390624A4 (en) * 2015-12-18 2019-07-10 The Regents of The University of California Modified site-directed modifying polypeptides and methods of use thereof
US9896696B2 (en) 2016-02-15 2018-02-20 Benson Hill Biosystems, Inc. Compositions and methods for modifying genomes
US9982279B1 (en) 2017-06-23 2018-05-29 Inscripta, Inc. Nucleic acid-guided nucleases
US10011849B1 (en) * 2017-06-23 2018-07-03 Inscripta, Inc. Nucleic acid-guided nucleases
WO2019051097A1 (en) * 2017-09-08 2019-03-14 The Regents Of The University Of California RNA-GUIDED ENDONUCLEASE FUSION POLYPEPTIDES AND METHODS OF USING SAME
AU2018383712B2 (en) * 2017-12-11 2025-09-04 Editas Medicine, Inc. Cpf1-related methods and compositions for gene editing
EP3821008A1 (en) * 2018-07-12 2021-05-19 Keygene N.V. Type v crispr/nuclease-system for genome editing in plant cells
WO2020092057A1 (en) * 2018-10-30 2020-05-07 Yale University Compositions and methods for rapid and modular generation of chimeric antigen receptor t cells
EP3874051A1 (en) * 2018-10-31 2021-09-08 Novozymes A/S Genome editing by guided endonuclease and single-stranded oligonucleotide
US12551560B2 (en) * 2019-09-09 2026-02-17 Scribe Therapeutics Inc. Compositions and methods for use in immunotherapy
EP4045651A1 (en) * 2019-10-14 2022-08-24 KWS SAAT SE & Co. KGaA Mad7 nuclease in plants and expanding its pam recognition capability
AU2021216418A1 (en) 2020-02-05 2022-09-01 Danmarks Tekniske Universitet Compositions and methods for targeting, editing or modifying human genes

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020530264A (ja) * 2017-06-23 2020-10-22 インスクリプタ, インコーポレイテッド 核酸誘導型ヌクレアーゼ
US20200354703A1 (en) * 2018-10-22 2020-11-12 Inscripta, Inc. Engineered enzymes
WO2020109412A1 (en) * 2018-11-28 2020-06-04 Keygene N.V. Targeted enrichment by endonuclease protection
WO2020254357A1 (en) * 2019-06-19 2020-12-24 F. Hoffmann-La Roche Ag Method for the generation of a protein expressing cell by targeted integration using cre mrna
WO2021067788A1 (en) * 2019-10-03 2021-04-08 Artisan Development Labs, Inc. Crispr systems with engineered dual guide nucleic acids

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ACTA CRYST., vol. 73, JPN6026026436, 2017, pages 664 - 671, ISSN: 0005897348 *
JOURNAL OF CELL SCIENCE, vol. 121, JPN6026026437, 2008, pages 1514 - 1525, ISSN: 0005897350 *
PROTEIN EXPRESSION AND PURIFICATION, vol. 133, JPN6026026438, 2017, pages 160 - 169, ISSN: 0005897349 *

Also Published As

Publication number Publication date
US20260009009A1 (en) 2026-01-08
WO2022236147A1 (en) 2022-11-10
CA3218053A1 (en) 2022-11-10
US20230340437A1 (en) 2023-10-26

Similar Documents

Publication Publication Date Title
CN115698278B (zh) 包含Cas12i2变体多肽的组合物及其用途
KR102666695B1 (ko) Rna를 편집하기 위한 방법 및 조성물
KR102851101B1 (ko) Rna를 편집하기 위한 방법 및 조성물
US11667903B2 (en) Tracking and manipulating cellular RNA via nuclear delivery of CRISPR/CAS9
CA3036926C (en) Modified stem cell memory t cells, methods of making and methods of using same
US20230340437A1 (en) Modified nucleases
EP4038190A1 (en) Crispr systems with engineered dual guide nucleic acids
US20250179481A1 (en) Compositions and methods for targeting, editing, or modifying genes
AU2022331424A1 (en) Persistent allogeneic modified immune cells and methods of use thereof
JP2024501892A (ja) 新規の核酸誘導型ヌクレアーゼ
US20250115903A1 (en) Compositions and methods for editing genomes
US20250388896A1 (en) Composition and methods for transgene insertion
HK40081918B (en) Methods and compositions for editing rna
WO2025259791A1 (en) Compositions and methods for tnpb and ωrna mediated targeting
WO2026083309A1 (en) Use of inhibitors or modulators of artemis in gene editing
HK40081918A (en) Methods and compositions for editing rna
KR20250021340A (ko) 유전자 및 세포 치료를 위한 tale 염기 편집기
EP4601650A2 (en) Compositions and methods for targeting, editing, or modifying genes
CN117136233A (zh) 包含变体Cas12i4多肽的组合物及其用途
HK40061041A (en) Methods and compositions for editing rnas
HK40056042A (en) Methods and compositions for editing rnas
HK40056042B (en) Methods and compositions for editing rnas

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250501

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250501

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260217

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260512

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20260630